Effect of Intradialytic Exercise on Serum FGF23 Levels and left ventricular structure and function in Hemodialysis Patients: : A randomized controlled trial pilot study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20260401024

Enrollment

Registered

2026-04-01

Start date

2025-09-30

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esrd patient on hd intradialytic exercise , esrd on hd ,fgf 23

Interventions

exercise,conventional hd without exercise

Experimental Behavioral,No Intervention Other

exercise ,no exercise

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Adults aged 18-85 years 2.On maintenance hemodialysis for at least 3 months 3.Able to perform exercise during dialysis

Exclusion criteria

Exclusion criteria: 1. History of myocardial infarction within the past 3 months,cardiac instability (angina, decompensated congestive heart failure, severe arteriovenous stenosis, uncontrolled arrhythmias,shortness of breath at rest or with activities of daily living (NYHA Class IV).. 2.Inability to sit, stand or walk unassisted (walking device such as cane or walker allowed) 3.Active infections or malignancies

Design outcomes

Primary

Measure	Time frame
fgf23 level 6 months serum fgf23 level,Fibroblast Growth Factor 23 6 months serum Fibroblast Growth Factor 23	—

Secondary

Measure	Time frame
lief 6 months echocardiogram,left ventricular ejection fraction 6 months echocardiogram,left ventricle mass 6 months echocardiogram	—

Countries

Thailand

Contacts

Public Contactseuppong naka

bhumibol adulyadej hospital

seubnaka24@gmail.com0870494435

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026